EG ·
SPECTRACEFOCURE 300 MG 10 CAP
SPECTRACEFOCURE 300 MG 10 CAP
Composition
These source-reported data require scientific review and are not treatment advice.
CEFDINIR
· AMOUNT_PER_UNIT
CEFDINIR
· AMOUNT_PER_UNIT
Registration
Packages and prices
SPECTRACEFOCURE 300 MG 10 CAPSULES
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| dinar 10 cap | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| CEDENIR 300 MG 10 CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| CEFDIN 300mg 10/CAP | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| CEFDIN 125mg SUSP 60ML | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| RAME-DINIR SUSPENSION 125 MG /5 ML 60ML | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| OMNICEF 300 MG 10 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| DINAR 125MG SUSP. 100ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 250MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| MAXIDINIR 125MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| EGYNIR 125 MG 60 ML SUSP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| SPASMOFREE 50 MG 20 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| RAME-DINIR 125MG/5ML SUSP. 60ML | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |